Zonsen Peplib Biotech
Zhuzhou
About Zonsen Peplib Biotech
Zonsen Peplib Biotech builds a peptide compound library and provides peptide drug discovery and development services for global pharmaceutical and biotech companies. The company's technology could compress the amino acid sequence information of about 500,000,000 peptides into 80,000 peptide compounds.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $34.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Apr 2021)
- Website: peplib.com
- Phone: 0731-221-88995
Industries & Categories
Biotechnology, Health Care, Product Research
Social Profiles
Canonical: https://fsome.com/organization/zonsen-peplib-biotech-6200 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.